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INTRODUCTION. 
                                India is a vast nation with the varied forms of health care 
problems of a developing country. The major medical problems include malnutrition and 
infections. Hence, less importance had been given to the specialty of critical care and the 
need is only recently being recognized. Although the technologic and scientific advances 
occur at a rapid rate in developed countries, these advances are variable in developing 
countries(1). With managed care and escalating health care spending even in an affluent 
society, measures to curtail spending are being implemented. With this in mind, 
developing countries with more basic health care needs have to prioritize their 
resources(1). Philosophically and economically, however, the impact of an untimely 
demise of the bread-winner from acute myocardial infarction or acute respiratory distress 
syndrome (ARDS) can be very devastating, particularly in developing countries with 
poor social security benefits. Furthermore, the prevalence of diseases that are reversible 
with intensive supportive care, such as those due to overdoses and infections, makes the 
role of intensive care units(ICUs) a necessity in every part of the world(1). The cost of 
ICU care per day in a tertiary care center in India (in 1991) was reported to be Rs 3200 
per patient ($167.70). Staffing, intravenous fluids, and drugs accounted for 75% of the 
cost of ICU care, whereas 15% accounted for laboratory investigations and 6.9% for 
disposables(1, 2).Whereas a study done in a medical ICU in a developed country showed 
the median cost per day during the same time period(1991) to be $1,357(3), almost seven 
times the cost in an ICU of a developing country. Hence the aim of a intensivist in a 
developing country should be to give the maximum effective care keeping in mind the 
limited resources available. The reason behind this study was to compare the cost 
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effectiveness of two suctioning systems and also to compare the incidence of ventilator 
associated pneumonia between the suctioning systems.  
                               Nosocomial infections (NIs) now concern 5 to 15% of hospitalized 
patients and can lead to complications in 25 to 33% of those patients admitted to ICUs(4). 
They are viewed as an inexorable tribute to pay to the more aggressive management of 
the population, characterized by the use of sophisticated technologies and invasive 
devices. The pathophysiology of NIs includes colonization of the host by potentially 
dangerous pathogens, such as microorganisms from exogenous or endogenous sources, 
including resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA), 
vancomycin-resistant enterococci (VRE), azole-resistant Candida spp, and extended-
spectrum ß-lactamase (ESBL) Gram-negative pathogens. Ventilator-associated 
pneumonia, catheter-related bloodstream infections, surgical site infections (SSIs), and 
urinary catheter-related infections account for > 80% of NIs.(5, 6) 
                                The Study on the Efficacy of Nosocomial Infection Control (7-
9)from the CDC has suggested that at least one third of NIs are preventable through 
infection control programs, which have been implemented in most centers during the last 
2 decades. Risk factors are well-identified and have been the target of efficient preventive 
measures.Several measures have been proposed to reduce the nosocomial infections and 
cross infections in ICU,taking into consideration the costs involved by adopting such 
measures and also their benefits and harms. 
                                 It has been suggested that closed endotracheal suctioning (CES) 
should reduce the risk of ventilator-associated pneumonia (VAP) by eliminating 
environmental contamination of the catheter before introduction into the endotracheal 
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tube (ETT). Another benefit of CES, often overlooked, is the limitation of aerosolization 
of infectious mucus particles. Thus, CES potentially has a role in preventing the spread of 
infection between patients and from patients to clinical staff (10). In recent years, there 
has been a global trend in ICUs to change from the established system of open 
endotracheal suctioning (OES) to the newer (and more costly) closed-suctioning 
systems(11). However, these potential advantages have not been shown to translate into 
clinically meaningful improvements, with several recent meta-analyses(12-14) having 
reproducibly demonstrated no benefit of CES over OES for a number of outcome 
measures, including incidence of VAP, mortality and length of ICU stay. These results 
are important for the implementation of evidence-based clinical practice but are not yet 
conclusive, considering that the meta-analyses themselves may have been underpowered 
to detect a true difference between suctioning systems(12). The majority of clinical trials 
included in the meta-analysis were conducted in first-world environments and it may, 
therefore, not be appropriate to directly apply these results to other ICU populations. 
                                       ICU’s in the developed world, where adequate bed spacing is 
present and there are no constraints of staffing and sufficient resources, the choice of 
suctioning systems may be based on staff preference as well as ocuupational health 
issues(11). However, the debate is clearly still open when addressing the specific 
challenges faced in ICUs in developing countries- issues which may predispose to a 
particularly high incidence of nosocomial infection.. These include inadequate staffing, 
patient overcrowding, an increased burden of infectious diseases, and resource 
limitations. With the high incidence of infectious diseases such as pulmonary 
tuberculosis, the focus should perhaps be broadened from the individual patient to the 
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wider ICU population (including staff and other patients). If CES were to reduce the risk 
of infection to nursing staff and patients, it may be worth the extra cost of using the 
system. However, until objective clinical benefit has been demonstrated, the use of CES 
cannot be justified in developing nations(11). 
                                      Hence this study was done comparing costs and clinical outcomes 
of open endotracheal suctioning with closed endotracheal suctioning in mechanically 
ventilated medical intensive care patients. This study is proposed to answer the question 
of the utility as well as benefit of closed endotracheal suctioning in the intensive care 
environment in a developing country. 
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AIMS AND OBJECTIVES OF THE STUDY     
      Aim:  
          To compare the cost and clinical outcomes with the use of  closed endotracheal 
suctioning, as compared to open endotracheal suctioning in the ICU setting of a tertiary 
care hospital.           
            
  
     Objectives: 
         To determine whether the use of closed endotracheal suctioning as compared to 
open endotracheal suctioning would result in  
1. Lower costs of therapy (in this situation costs involved with suctioning). 
2. A reduction in the incidence of ventilator associated pneumonia (VAP).  
3. A similar incidence of left basal collapse determined radiologically. 
4. Lower mortality. 
5. A reduction in the duration and extent of desaturation. 
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REVIEW OF LITERATURE 
                 Literature review structure 
1) Critical Care in India-a emerging speciality(12) 
2) Endotracheal suctioning and different suctioning methods.(13) 
3) Closed endotracheal suctiong systems.(13) 
4) Advantages and disadvantages of different suctioning systems.(15) 
5) Ventilator associated pneumonia.(16)                       
6) Type of suctioning and ventilator associated pneumonia.(36) 
7) Type of suctioning and its effect on environmental contamination.(37) 
8) Type of suctioning and its effect on ventilatory and hemodynamic 
parameters.(41) 
9) Type of suctioning and cost effectiveness.(43) 
10) Type of suctioning and nursing related outcomes.(45) 
11) Metaanalysis comparining the open and closed suctioning systems.(46) 
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CRITICAL CARE IN INDIA-AN EMERGING SPECIALITY 
 
                           Critical care is still an emerging specialty in developing countries 
like India. India with over a billion population with majority living in villages is still 
deficient in critical care facilities with not enough penetration into the villages. The 
spectrum of diseases widely varies in developing countries as compared to developed 
countries. Fulminant infections and other problems peculiar to poor tropical developing 
countries form an extremely important group of patients necessitating critical care. What 
is more, intensive care in this group of patients is extremely rewarding, with severe 
tetanus being a classic example (1, 15). Thus, critical care units of large teaching 
hospitals and of district hospitals serving small towns and their adjacent villages deal 
with a higher proportion of patients with acute infections, trauma, poisoning, severe 
burns, and poisonous snake bites(1). Poisonings, in fact, form an extremely important 
cause of emergency admission to medical ICUs. Organophosphorus poisoning is one of 
the leading causes of suicide in India, and when managed well can give gratifying results. 
Hence any intervention or a procedure which would cut down ICU costs or reduce 
nosocomial infections would make ICU care more affordable(1).One such area would be 
endotracheal suctioning and prevention of ventilator associated pneumonia where much 
studies are not available from developing countries. A brief discussion about the 
endotracheal suctioning and ventilator associated pneumonia is given below. 
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ENDOTRACHEAL SUCTIONING AND DIFFERENT SUCTIONING 
METHODS. 
                           Endotracheal suctioning is performed in intubated mechanically 
ventilated (MV) patients as a routine, essential part of care to clear endotracheal 
secretions.   
Two methods of endotracheal suctioning are in practice –the open endotracheal 
suctioning (OES) system where suctioning is performed after disconnecting the 
respiratory circuits and using sterile single use suction catheters and the closed 
endotracheal suctioning (CES) system, where suctioning  is performed without 
disconnecting the respiratory circuit, and uses multi-use in-line catheters that are enclosed 
in a sheath along with the respiratory circuit.  
 
CLOSED ENDOTRACHEAL SUCTIONING SYSTEM. 
                              Closed-circuit suction systems were introduced nearly 25 years ago as 
a method to reduce complications associated with the traditional suctioning procedure. 
CES device consists of a T-shaped suction union which incorporates a re-usable suction 
catheter. The catheter is withdrawn into a flexible plastic film sleeve between successive 
suction procedures which prevents contact between the catheter and the environment and 
permits the same suction device to remain in position in the breathing system before it is 
replaced. The tip of the catheter protrudes into the lumen of the catheter mount through a 
close-fitting flange. The catheter is grasped through its sleeve to advance it into the 
tracheal tube connector and on into the 
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                                          Figure 1:Example of a closed suction catheter(10).  
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tracheobronchial tree. The flange provides a gas-tight fit around the catheter and prevents 
the loose-fitting sleeve from being inflated during IPPV. It also wipes any secretions 
from the outer surface of the catheter as it is withdrawn. The catheter is fitted with a 
vacuum control valve which has a spring-based piston action. This device must be 
compressed continuously to maintain suction to prevent suction from being applied 
continuously to the airways inadvertently. The devices were provided with an irrigation 
port (with one way valve) on the catheter mount so that irrigation fluid could be instilled 
through the port. This fluid was aspirated through the catheter, by operating the suction 
valve, thereby washing it clear of accumulated secretions thus allowing lavage and 
irrigation without leakage of ventilation and secretions. It also maintains closed circuit 
during procedures such as fiberoptic bronchoscopy and mucus sampling.(Figure 1)  
 
PROPOSED ADVANTAGES AND DISADVANTAGES OF DIFFERENT 
SUCTIONING SYSTEMS. 
                           The purported advantages of closed-circuit suctioning include: no need 
to break the circuit; maintenance of ventilation, oxygenation, and positive end-expiratory 
pressure; and reduced environmental and caregiver contamination. This mode of 
suctioning has comparatively fewer physiological disturbances and consequences during 
suctioning(16, 17) as well as ease of use, given that only one operator is required for 
suctioning(18). Further, CES is postulated to reduce VAP rates by decreasing 
environmental contamination during suctioning (10).These potential advantages have led 
to the conduct of several randomized controlled trials (RCT) that compared CES and 
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OES. These individual trials failed to show a superiority of one type of suctioning over 
the other(12).  
                        The disadvantages of CES include the risk of producing high negative 
pressures if the amount of air suctioned exceeds the gas flow delivered to the patient by 
the ventilator(19); reduced efficiency in clearing thick secretions from the 
airways(20);and the high financial cost of the system(21),which may have replaced daily 
in order to avoid microbial lower respiratory tract colonization(22).Practically, there is 
also a risk of not withdrawing the catheter completely after the suctioning event, thus 
partially occluding the ETT and increasing airway resistance. These disadvantages may 
actually favor the use of OES(11). 
                         A recent meta-analysis performed in our institution(12)suggested the lack 
of superiority of open over closed suctioning.  The authors however proposed that the 
studies that were included in the meta-analysis comprised of trials performed in the 
Western environment and hence could not be applied to our cohorts of patients in our 
country. Further they proposed that the meta-analysis was under powered to answer the 
question and that there were methodological weakness in the studies that limited 
generalizability to the average ICU patient(12). 
 
VENTILATOR ASSOCIATED PNEUMONIA (VAP) 
                    Ventilator-associated pneumonia(VAP) refers specifically to nosocomial 
bacterial pneumonia that has developed in patients who are receiving mechanical 
ventilation(23). VAP is defined as pneumonia occurring more than 48 hours after 
endotracheal intubation and initiation of mechanical ventilation.(24) Ventilator-associated 
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pneumonia that occurs within 48 to 72 hours after tracheal intubation is usually termed 
early-onset pneumonia; it often results from aspiration, which complicates the intubation 
process. Ventilator-associated pneumonia that occurs after this period is considered late-
onset pneumonia.(23). Ventilator-associated pneumonia (VAP) is common in the 
intensive care unit (ICU), affecting 8 to 20% of ICU patients and upto 27% of 
mechanically ventilated patients(25).Early-onset ventilator-associated pneumonia is most 
often due to antibiotic-sensitive bacteria (eg;oxacicillin sensitive Staph 
Aureus,Haemophilus Influenzae and Streptococcus pneumoniae),whereas late-onset VAP 
is frequently caused by antibiotic-resistant pathogens (e.g., oxacillin-resistant Staph. 
aureus, Pseudomonas aeruginosa, acinetobacter species, and enterobacter species)(27-29). 
Microorganisms responsible for VAP may differ according to the population of patients 
in the ICU, the durations of hospital and ICU stays, and the specific diagnostic method(s) 
used. The high rate of respiratory infections due to GNB in this setting has been 
repeatedly documented(24).A study done in one of the tertiary hospitals in India also 
found gram negative organisms to be the main isolates from patients who developed 
Ventilator associated pneumonia(26).(Table 1) 
 
Epidemiology of VAP. 
                             VAP has an incidence ranging from 6.8% to 44% (18, 30-32)However 
some studies done in  India showed incidence rates of 16.7%(33)and 47%(34)In contrast, 
Cook and coworkers demonstrated in a large series of 1,014 mechanically ventilated  
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Table 1- Etiology of ventilator associated pneumonia from a study done in a tertiary care 
centre in India(26).  
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patients that, although the cumulative risk for developing VAP increased over time, the 
daily hazard rate decreased after Day 5 (35).The risk of VAP is highest early in the course 
of hospital stay, and is estimated to be 3%/day during the first 5 days of ventilation, 
2%/day during Days 5 to 10 of ventilation, and 1%/day after this (35). Early-onset VAP, 
defined as occurring within the first 4 days of hospitalization, usually carry a better 
prognosis, and are more likely to be caused by antibiotic-sensitive bacteria. Late-onset 
VAP (5 days or more) are more likely to be caused by multidrug-resistant (MDR) 
pathogens, and are associated with increased patient mortality and morbidity(25).                      
However, patients with early-onset HAP who have received prior antibiotics or who have 
had prior hospitalization within the past 90 days are at greater risk for colonization and 
infection with MDR pathogens and should be treated similar to patients with late-onset or 
VAP(Table 2).(36) 
                                                               Nosocomial pneumonia is a leading cause of 
death from hospital-acquired infections, with an associated crude mortality rate of 
approximately 30 percent(37). The incidence of VAP-attributable mortality is difficult to 
quantify due to the possible confounding effect of associated conditions, but VAP is 
thought to increase the mortality of the underlying disease by about 30% (37).Mortality 
rates in patients with VAP range from 20 to 50% and may reach more than 70% when the 
infection is caused by multi-resistant and invasive pathogens (34, 37, 38).                               
It has been found that VAP increased hospital stay by  10 to 32 days(39). These 
prolonged hospitalizations underscore the considerable financial burden imposed by the 
development of VAP. 
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Table 2-Risk factors for multidrug-resistant pathogens causing ventilator associated pneumonia(36) 
 
However, a precise and universal evaluation of such overcosts is difficult. Cost analysis 
is, indeed, dependent on a wide variety of factors that differ from one country to another, 
including health care system, organization of the hospital and the ICU, the possibility of 
patients being treated by private practitioners, cost of antibiotics, and so on(24). 
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Figure 2-Pathogenesis of Ventilator-Associated Pneumonia(40) 
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Pathogenesis 
                                  The pathogenesis of ventilator-associated pneumonia usually 
requires that two important processes take place: bacterial colonization of the 
aerodigestive tract and the aspiration of contaminated secretions into the lower airway. 
Critical illness leads to the rapid colonisation of the oropharynx with potentially 
pathogenic bacteria caused by changes in host defences, previous antibiotic exposure, and 
changes in either the bacterial adhesins or host surface receptors. Any procedure for 
preventing VAP should be aimed at preventing these two processes(figure 2)(40, 41). 
                                   Events important in the progression to pneumonia in intubated 
patients begin with oropharyngeal colonization by potentially pathogenic bacteria. These 
events leading to pneumonia are summarized in(Figure 3)(42). 
                                 The presence of invasive medical devices is an important contributor 
to the pathogenesis and development of ventilator-associated pneumonia. Many patients 
have nasogastric tubes that predispose them to gastric reflux and increase the potential for 
aspiration(11). The ventilator circuit and respiratory-therapy equipment may also 
contribute to the pathogenesis of ventilator-associated pneumonia if they become 
contaminated with bacteria, which usually originate in the patient's secretions(41, 43). 
Risk factors 
Risk factors provide information about the probability of lung infection developing in 
individuals and populations. Thus, they may contribute to the elaboration of effective 
preventive strategies by indicating which patients might be most likely to benefit from 
prophylaxis against pneumonia(24). Intubation is the most important risk factor 
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Figure 3- Potential sources of bacteria causing ventilator-associated pneumonia. Bacteria 
residing in the oropharynx and gastrointestinal tract can contaminate the subglottic 
secretion pool, as demonstrated. Subglottic secretions above the endotracheal tube cuff 
are aspirated into the trachea and disseminated into the distal airways and lung 
parenchyma by the force of the ventilator(42). 
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for developing nosocomial pneumonia(44).Although it is difficult to differentiate between 
the risk imposed by the mechanical ventilator and its associated tubing and the presence 
of a tracheal tube, it is known that the incidence of VAP is less when non-invasive 
ventilation is used(45).Other major risk factors which have been found to contribute 
towards VAP is given in Table 3(24). 
 Diagnosis of VAP. 
Various strategies have been developed in the last two decades to diagnose pneumonia in 
critically ill patients presenting with fever and/or new pulmonary infiltrates on the chest 
X-ray.These consist mainly of quantitative bacterial cultures of specimen. bronchoscopic 
and nonbronchoscopic techniques. The accurate diagnosis of VAP still remains 
problematic. Standard diagnostic features of pneumonia such as fever, tachycardia, 
leucocytosis, purulent sputum, and consolidation on the chest radiograph are unreliable in 
the critically ill mechanically ventilated patient(46). Fever, leucocytosis, and tachycardia 
are non-specific findings and are seen in any critically unwell patient with an 
inflammatory response to an insult, for example, trauma, burns, pancreatitis, etc. Purulent 
sputum may be caused by tracheobronchitis and does not always signify parenchymal 
involvement(47). Infiltrates on the chest radiograph can be caused by a number of non-
infective conditions including pulmonary oedema, haemorrhage, and contusions(48). 
But more importantly, the use of the “simple” clinical judgement integrating “classical” 
clinical signs may result in the overtreatment of patients without VAP and in the 
undertreatment of up to one third of patients with microbiologically proven 
VAPs(4).However, the use of invasive procedures to diagnose VAP is still a matter of 
debate among clinicians(49, 50). 
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Table 3-Risk factors for the development of ventilator associated  pneumonia(24). 
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Most authors would agree that the histological examination of lung tissue coupled with 
the quantitative culture of the tissue may represent an acceptable gold standard, but this is 
also adequately judged as too invasive in ventilated patients(51).Given the limitations of 
standard clinical methods and the fact that lung biopsy is often not feasible or definitive 
in this setting,(52) an easily applicable diagnostic method has been sought. 
Clinical criteriae. 
                                   The clinical criteriae for diagnosis of VAP was proposed by 
Johanson etal in 1972. Most researchers have adopted or modified the definition of 
pneumonia originally used by Johanson et al:’(1) radiographic appearance of a new or 
progressive pulmonary infiltrate; (2) fever; (3) leukocytosis; and (4) purulent 
tracheobronchial secretions. The combination of infiltrates on the chest radiograph with 
two of three clinical criteria had a reasonable diagnostic accuracy(53) In a postmortem 
study by Fabregas et al., when findings on histologic analysis and cultures of lung 
samples obtained immediately after death were used as references, a new and persistent 
(>48-h) infiltrate on chest radiograph plus two or more of the three criteria (i) fever of 
>38.3°C, (ii) leukocytosis of >12 x 109/ml, and/or (iii) purulent tracheobronchial 
secretions had a sensitivity of 69% and a specificity of 75% for establishing the diagnosis 
of VAP(54) When all three clinical variables were required for the diagnosis, the 
sensitivity declined further (23%); the use of a single variable resulted in a decrease in 
specificity (33%).The clinical criteria yielded a sensitivity of 62% and a specificity of 
84% in a study using microbiological criteria for VAP(55). Two necropsy studies have 
also shown similar results (sensitivity 60% and specificity 80%) when evaluating clinical 
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criteria(56).As was mentioned earlier individual parameters were found to be very 
nonspecific for the diagnosis of ventilator associated pneumonia. 
Fever 
The appearance of a new episode of fever (>38.3 °C) is often the sign for the clinician 
that the ventilated patient may be developing VAP, and may trigger further diagnostic 
procedures. But it has been found that as many as 50% of ventilated patients may develop 
fever for causes that are distinct from pneumonia, particularly in patients with ARDS.(57) 
It is also noteworthy that VAP can develop without fever, in particular in those patients 
with continuous veno-venous hemodialysis, receiving NSAIDs or paracetamol, or simply 
because the sepsis syndrome can be associated with hypothermia(51) Therefore, the 
introduction of antibiomicrobial therapy for the treatment of VAP suspected on the basis 
of the sole fever should be avoided, and conversely 
the absence of fever should not rule out VAP. 
Tracheal aspirates 
It has been shown that the increased volume of tracheal aspirates becoming purulent in 
the last 48 hours was predictive of VAP(58) The routine culture of tracheal aspirates has 
been understudied as an indication for the development of VAP. In patients intubated for 
a long period of time, the distinction between colonization and infection is certainly 
problematic. 
Blood leukocytosis 
Leukocytosis (>11,000 WBC/mm3) or leucopenia (<5,000 WBC/mm3) are frequently 
used at the bedside as a help to diagnose an infection but is not useful for the diagnosis of 
VAP.(51) 
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Radiographic criteria 
The development of new pulmonary infiltrates or opacities on the chest X-ray is 
frequently, with a new fever, the bedside criteria that will trigger the suspicion of a 
VAP(57). The interpretation of the chest radiogram is often problematic in ventilated 
patients. This is due to the frequent structural lung abnormalities in ventilated patients 
(ARDS, COPD), and the possible fluid overload or cardiac failure (lung edema) 
contributing to the opacities. The diagnosis of VAP based on radiologic criteria suffers 
from both overinterpretation (false positives) and underinterpretation (false negatives). In 
the study by Fagon et al., only 31% of the patients with new radiological infiltrates were 
found to have a microbiologically proven VAP(59) This is corroborated by the study of 
Meduri et al. who found only 42% of the new infiltrates in patients with ARDS could be 
attributed to an infectious cause(57) .The “best” radiological sign for pneumonia seems to 
be the presence of an air bronchogram, as demonstrated in a radiological/post-mortem 
examination VAP study(60).Even this sign was associated with a positive predictive 
value of only 68%. 
 
CPIS score 
 
                                         As indicated above, none of the clinical variables taken 
separately are predictive enough to be useful at the bedside for the diagnosis of VAP. The 
association of some clinical variables together seemed to increase the diagnostic yield. 
With the aim of simulating and quantifying the “clinical judgement”, Pugin at al 
developed in 1991,a score based on 6 variables: fever, leukocytosis, tracheal aspirates, 
30 
 
oxygenation, radiographic infiltrates, and semiquantitative cultures of tracheal aspirates 
with Gram stain, the clinical pulmonary infection score (CPIS,Annexure 1)(58). The 
study also found good correlation between clinical score and quantitative 
bacteriology.CPIS score has been used in various studies mainly for diagnosis and 
prognostification of the ventilator associated pneumonia and for deciding the duration of 
antibiotic therapy.The score varies from 0 to 12 points. It was  found that a score 6 
points was highly predictive of a high burden of bacteria in the lower airways measured 
by quantitative cultures of the BAL fluid. The advantage of the score over other 
associations of clinical variables was that it was more flexible and allowed for the signs 
not to be all present at the same time(58). This greatly increased its sensitivity to 
diagnose VAP. 
                                   The usefulness of the CPIS was confirmed in studies by Flanagan et 
al., and Papazian et al(61, 62). These authors found that a threshold of >6 points was 
associated with sensitivities of 72-85% and specificities of 85-91% to diagnose VAP, a 
diagnostic yield that matches that of invasive bronchoscopic techniques with quantitative 
cultures(Table 4).9 In a recent Spanish study, the CPIS, when compared with post-
mortem histological evidence of pneumonia, had a lower sensitivity and specificity (77 
and 42%, respectively) to diagnose VAP(54). The study also used the CPIS with success 
as a quantitative assessement of the efficacy of oropharyngeal decontamination with 
topical antibiotics to prevent the development of VAP.(63). The CPIS was further used in 
an interesting study by Singh et al(64). These authors utilized the CPIS (cut-off point >6) 
as a guide for indicating or withdrawing antibiotic therapy in patients with suspected 
VAP (= new pulmonary infiltrates). In patients with new infiltrates, but low risk (CPIS 
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<6), the antibiotic therapy was discontinued if patients remained with a low CPIS after 72 
hrs. In patients with high CPIS at the time of admission or at 72 hrs, the antibiotic therapy 
was continued. This algorithm based on the CPIS was associated with a dramatic 
reduction in antibiotic use (28 vs 97%, p<0.0001) and duration (3 vs 10 days, p<0.0001), 
as well as a marked reduction in overall and antibiotic-related costs(64). Finally, an 
intriguing report by Fagon et al suggests that in patients suspect of having VAP, the 
noninvasive “clinical” management was associated with a significantly higher mortality 
(p=0.022) compared to an invasive approach with bronchoscopic sampling of the lower 
airways and quantitative cultures(65).This study contrasts with others in which such a 
difference in outcome was not found(66, 67). 
Microbiological Diagnosis of VAP 
Despite numerous publications on the subject, controversy still exists on the optimal 
method of microbiological diagnosis of VAP(68). As the trachea and tracheal tube rapidly 
become colonised with bacteria in the critically ill patient, cultures of sputum or tracheal 
aspirates may simply yield colonising organisms. The argument therefore revolves around 
whether specimens of lower respiratory tract secretions should be collected in an invasive 
manner or whether quantitative analysis of non-invasively collected tracheal aspirates is 
sufficient. Analysing samples using quantitative culture techniques theoretically permits 
differentiation between oropharyngeal organisms present at low concentrations and the 
higher concentrations of pathogenic organisms. Blood cultures have limited value in the 
diagnosis of VAP and have a very low sensitivity for detecting the pathogenic organism 
responsible for the pneumonia(69).  
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Table 4 : Sensitivity and specificity of CPIS score. 
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Quantitative cultures of tracheal aspirates 
 
Collection of material for microbiological analysis using this technique is quick, simple, 
and widely available. While there is some evidence to suggest that the use of this method 
has a high false positive rate in the diagnosis of VAP, other studies suggest that 
quantitative analysis of tracheal aspirates offers a reliable alternative to invasive 
techniques(66, 70, 71). A prospective study by Sanchez-Nieto and colleagues comparing 
quantitative analysis on non-invasively collected tracheal aspirates with invasively 
collected respiratory samples in 51 patients with suspected VAP showed a high degree of 
concordance in bacteriological results and no difference in mortality(66). Another study 
involving 76 patients with suspected VAP, who were randomly allocated to either 
invasive or a non-invasive diagnostic strategy, also showed that the invasive strategy had 
no benefit(67) Both studies used a threshold of 105 colony forming units/ml to distinguish 
tracheal colonisation from true VAP.  
A non-invasive strategy of diagnosis in those suspected of VAP seems to be associated 
with higher antibiotic use(65) 
Invasive techniques of sampling distal airways 
 
There are a number of problems associated with the use of bronchoscopy; the expertise 
and equipment required is not always available and sampling is often followed by a 
period of hypoxaemia(72).Three comparatively small single centre studies comparing 
mortality in patients with suspected VAP managed on the results obtained by either 
invasive studies or quantitative analysis of tracheal aspirates failed to find any difference 
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in mortality(66, 67, 73). Most recently a meta-analysis of randomised, controlled trials of 
invasive diagnostic strategies in suspected VAP reported that an invasive approach did 
not change mortality (odds ratio 0.89, 95% confidence interval 0.56 to 1.41), but did 
change antibiotic use (odds ratio for change in antibiotic management after invasive 
sampling, 2.85, 95% confidence interval 1.45 to 5.59)(74).  
Currently two techniques are commonly used to obtain distal airway samples with the 
bronchoscope; BAL or protected specimen brushing (PSB). 
                                           The accuracies of tracheobronchial aspirates, protected 
specimen brush, bronchoalveolar lavage fluid, and protected bronchoalveolar lavage fluid 
specimens for the presence of pneumonia with microbiologically active pneumonia as the 
reference test is given in (Table 6)(54).  Strategies to be adopted to prevent VAP is given 
in (Table 5). 
Antibiotic treatment of ventilator associated pneumonia 
 
                               Selection of initial appropriate therapy is an important aspect of care 
for hospitalized patients with serious infections. Patients at risk for infection with these 
organisms should initially receive a combination of agents that can provide a broad 
spectrum of coverage to minimize the potential for inappropriate antibiotic treatment. In 
the therapy of suspected pseudomonal infection, therapy should involve a selected ß- 
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Table 5:Selected VAP Prevention Strategies Abstracted From Recent Guidelines 
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Table 6; Accuracy of non-invasive and invasive diagnostic techniques for ventilator 
associated pneumonia 
 
 
Table 7:Initial empiric therapy for hospital acquired pneumonia,ventilator associated 
pneumonia,and health care associated pneumonia in patients with late onset disease or 
risk factors for multidrug resistant pathogens(54). 
37 
 
lactam plus either an antipseudomonal quinolone or an aminoglycoside. The choice of 
agents should be based on local patterns of antimicrobial susceptibility, and anticipated 
side effects, and should also take into account which therapies patients have recently 
received (within the past 2 weeks), striving not to repeat the same antimicrobial class, if 
possible.Appropriate antibiotics for the initial management of  Ventilator associated 
pneumonia on the basis of time of onset of disease and risk for MDR pathogens, as 
outlined in tables 7(54)and and a general guide to antimicrobial therapy is given in table 
8(24). 
 
Type of suctioning and ventilator associated pneumonia 
                                         While there is no resounding proof that closed suctioning 
reduces VAP compared to open suctioning, there is also no proof that it increases the risk 
of VAP. In turn, while observational studies suggest greater colonization of closed-circuit 
suction catheters, there is no evidence that this increases the risk of VAP. The 
conventional wisdom that fewer breaks of the circuit result in a lower risk of 
contamination clearly supports the use of closed-circuit suctioning(75-77). Combes et al 
randomized 104 patients with negative tracheal aspirates at study entry to open (n _ 50) 
or closed suctioning (n _ 54). They found that the incidence of VAP was 3.5 times greater 
in the open-circuit suctioning group and that VAP increased the length of stay by 17 
days(76)..In the recently published metaanalysis,the authors concluded that using closed 
suction did not provide any benefit on VAP incidence, mortality, or ICU stay of MV 
patients. Rather suctioning with closed systems was associated with longer MV duration 
(weighted mean differences: 0.65 days, 95% CI 0.28–1.03) and higher colonization of the 
respiratory tract (OR=2.88, 95% CI 1.50–5.52) than open suctioning system.. 
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                                         Interestingly, the relevant guidelines seem to be inconclusive on 
the usefulness of closed TSS in preventing VAP in MV patients. In the most recent 
guidelines for preventing health-care-associated pneumonia published (2004) by the 
Centres for Disease Control and Prevention, the preferential use of either the closed TSS 
or the open TSS for VAP prevention was considered as an unresolved issue(78).In the 
other hand, the Canadian Critical Care Trials Group and the Canadian Critical Care 
Society (2004) concluded that type of TSS (closed or open) has no effect on VAP 
incidence; however, they encouraged the use of closed TSS based on cost 
considerations(79).A year earlier (2003), the American Association for Respiratory 
Care’s recommendation regarding this issue was that closed TSS should be considered 
part of a VAP prevention strategy(80). Finally, the European Task Force on VAP (2001) 
mentioned that there is only limited evidence that closed TSS usage is able to reduce VAP 
incidence at the expense of a clearly increased cost and, thus, no recommendation has 
been made(81).  
Type of suctioning and effect on environmental contamination. 
                                    The conventional method of tracheal toilet requires that the 
breathing system is opened to atmosphere at the tracheal suction connector to permit the 
introduction of a sterile suction catheter by a sterile gloved hand. The catheter and the 
glove are discarded after single patient use in order to minimise bacterial contamination. 
It is usual for the function of the ventilator to be interrupted during the procedure. An 
aerosol of droplets of condensate and tracheal secretions can be seen clearly to be 
expelled from the connector during passive exhalation by the patient and during the 
positive pressure phase of ventilation by the machine. 
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Table 8: Guide to antimicrobial therapy(24). 
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Ventilators which provide continuous positive airway pressure (CPAP) cause a 
continuous high flow of gas to be delivered from the open suction connector, and this 
tends to increase both the quantity and the range of resulting environmental 
contamination. It is reasonable to suppose that extensive contamination of the 
environment and the operator occurs directly as a result of the use of this method of 
tracheal suction(10). 
                                       In developing countries where the space allocated to individual 
beds may be restricted, close proximity of beds may further compound the problem 
leading to environmental contamination of the respiratory tract. The authors of the 
recently concluded meta-analysis(12) proposed that studies comparing CES with OES 
may thus be more relevant in the developing world and may not be paramount issues in 
countries where occupational health and safety concerns preclude the use of OES and 
where the ease of use as well as reduced nursing time with CES may over-ride cost 
concerns.                                      There are studies which looked at the environmental 
contamination while using the suction catheters.One study showed that the increase in the 
postsuction colony count detected by the Reuter test when the closed catheter was used (+ 
6.7) was significantly lower (p < 0.001) than the increase associated with the open 
technique (+25.3). The organisms were identified up to one metre away from the suction 
site with conventional open suction while closed catheter failed to register any 
contamination.(Table 9 and Table 10)(10). This finding is consistent with the view that 
the closed catheter effectively eliminates environmental contamination by organisms 
from the patient’s respiratory tract(10). One study reported that the use of closed-circuit  
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Table 9: Total colony counts measured by air sampling before and 
after tracheal suction using open or closed suction systems(10). 
 
 
 
Table 10: Comparison of colony counts on settle plates before and 
after tracheal suction by the open or closed methods(10). 
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suction systems results in significantly less environmental contamination, compared to 
open techniques(10)Though this had no impact on VAP, it does reduce exposure of 
caregivers. 
Type of suctioning and effect on ventilatory parameters. 
                       Multiple studies have been done to look at the hemodynamic parameters 
while using the open and closed suction catheters.Open suctioning involves 
disconnection of ventilator from the endotracheal tube.Disconnection itself results in 
airway pressure drop and loss of lung volume,but a further volume decrease is observed 
during suctioning(82) due to the generation of negative pressure in the airway.Therefor 
open suctioning may lead to alveolar collapse and potentially hinders efforts aimed at 
maintaining lung volume.Hyperoxygenation and hyperinflation maneuvers are often used 
before and after open suction to limit hypoxemia(17, 83, 84) but do not directly prevent 
lung collapse. 
                         However closed systems allow non interrupted ventilatory support during 
suctioning and have been shown to limit or avoid gas exchange impairment and 
hemodynamic disturbances due to the maneuver(17, 84).A study showed major drop in 
lung volume during open suction compared to suction with closed suction,SpO2 started 
to decrease significantly during the open suction and there was an increase in mean 
arterial pressure during the open suctioning.Increases in mean arterial pressures could 
result from hypoxemia,airway manipulation and tracheal stimulation(17, 84).Closed 
suctiong allowed the maintainance of lung volumes,of ventilation and of positive airway 
pressure during suctioning and avoided decreases in SPo2 and changes in MAP.  
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                                  Another study conducted in medical and surgical ICU’s found that 
the pO2 dropped significantly compared to baseline values in the open-system method 
when PEEP was >8 cm H2O Five and 15 min after suctioning(85). The maintenance of 
positive end-expiratory pressure during closed-circuit suctioning has been shown to 
reduce hypoxemia from lung derecruitment(84, 86).Johnson etal found that  open 
endotracheal suctioning resulted in significant increases in mean arterial pressure 
throughout the suctioning procedure(17). Both methods resulted in increased mean heart 
rates. However, 30 secs after the procedure, the open-suction method was associated with 
a significantly higher mean heart rate than was the closed method. Closed suctioning was 
associated with significantly fewer dysrhythmias. Arterial oxygen saturation and systemic 
venous oxygen saturation decreased with open suctioning. In contrast, arterial oxygen 
saturation and systemic venous oxygen saturation increased with the closed suction 
method. There was no difference between the two methods in the occurrence of 
nosocomial pneumonia(17). 
                                  A metaanalysis done in 2006 showed that Compared with 
OTSS(open tracheal suctioning system), endotracheal suctioning with CTSS(closed 
tracheal suctioning system) significantly reduced changes in heart rate (four studies, 85 
patients; weighted mean difference, -6.33; 95% confidence interval, -10.80 to -1.87) and 
changes in mean arterial pressure (three studies, 59 patients; standardized mean 
difference, -0.43; 95% confidence interval, -0.87 to 0.00) but increased colonization (two 
studies, 126 patients; relative risk, 1.51; 95% confidence interval, 1.12-2.04). No 
conclusions could be drawn with respect to arterial oxygen saturation (five studies, 109 
patients), arterial oxygen tension (two studies, 19 patients), and secretion removal (two 
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studies, 37 patients). Based on the results of this meta-analysis, the authors concluded 
that there is no evidence to prefer CSS more than OSS(13). 
 
Type of suctioning and cost effectiveness. 
                             One of the main factors influencing the care in ICU especially in 
developing countries is the cost factor.Unfortunately there are no credible studies looking 
at the cost effectiveness of the two types of suctioning from the developing countries.In a 
randomized, controlled study by Lorente etal, VAP incidence and costs of suctioning 
were assessed in 457 mechanically ventilated patients assigned to the open-suctioning 
technique or to a closed system which allows partial (suctioning catheter with its 
protected covering sheath) or complete system change. The closed system was changed 
not routinely but only when it presented mechanical failure or visible soil (partial 
change), or when the patient needed reintubation (complete change). No difference was 
found between groups in the rate and incidence density of VAP or in the distribution of 
micro-organisms responsible for VAP. Costs of suctioning were similar between open 
and closed  
suctioning, but they varied according to the length of mechanical ventilation: costs 
associated with use of the closed system were higher than those with open-suctioning 
when mechanical ventilation was shorter than 4 days and lower when the length of 
mechanical ventilation was greater than 4 days.They also found that , the aspiration cost 
was less expensive in the CTSS without periodic change group than in the OTSS group 
($1.89 × 1.53 vs $2.45 × 0.71 per patient-day, P < 0.0001).They also concluded that  
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Table 11:Costs:comparing open and closed suction systems(87). 
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 CTSS without periodic change decreased the aspiration cost and did not modify the VAP 
incidence(21). 
Because in-line suction catheters are parts of the ventilator circuits, they should be 
changed for each new patient and as clinically indicated and not at regular intervals for 
infection control purposes(79). Such a policy is highly cost-effective and could decrease 
the risks of patient cross-contamination and healthcare provider exposure to respiratory 
secretions during changes of the closed system(79). The maximum safe duration of 
closed-suction systems in use on a single patient, however, remains 
unknown(88).Another study done by Johnson etal found that Open endotracheal 
suctioning cost $1.88 more per patient per day and required more nursing time compared 
to closed suction without any difference in VAP rates(17).Most of the other studies have 
shown that costs were much higher for the closed suction.(Table 11)(87). 
 
Type of suctioning and nursing related outcomes.  
                              OS is performed by disconnecting the patient from the ventilator and 
introducing a suctioning catheter into the endotracheal tube(ETT). Nursing personnel 
using sterile gloves are necessary for this procedure. One person opens the connection 
between the ETT and the ventilatory tubing system; the second person introduces a 
suctioning catheter and performs flushes. Usually, two to three suctioning catheters are 
necessary to complete suctioning. Different catheters are used for suctioning the trachea 
and the oropharynx.While closed  suction catheter is attached between the ETT and the 
ventilatory tubing system. This system, included in the ventilatory circuit, allows 
introduction of suctioning catheters into the patient’s airway without the necessity of 
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disconnecting the patient from the ventilator(89). But suctioning of the oropharynx with a 
open suction catheter is needed while using closed catheter for the endotracheal tube.   
                                                               Results from Zielmann 1992(90) and Johnson 1994(17) 
reported that nurses needed more time to suction patients with OTSS. Zielmann 1992 
observed that nurses averaged 3.5 minutes (range of 2 to 6 minutes) to suction patients 
with OTSS, whereas suctioning patients with CTSS(closed tracheal suctioning system) 
took one minute less (average = 2.5 minutes, range 2 to 4minutes). Johnson 1994 
reported overall shorter times than those of Zielmann 1992 but the differences between 
groups remained. These authors reported an average of 2.5 minutes for the OTSS in 
comparison with the 1.5 minutes needed to suction with the CTSS(91). 
META ANALYSIS OF TRIALS DONE ON CLOSED AND 
OPEN ENDOTRACHEAL SUCTIONING SYSTEM. 
                                                                There have been multiple metaanalysis done 
regarding the usefulness of closed endotracheal suctioning system over open endotracheal 
suction.None of the Metaanalysis found any benefit in using CTSS over OTSS. 
                                               Metaanalysis done by Siempos etal(92) which looked at 9 
Randomized control trials  and found no difference in the incidence of VAP between 
patients managed with closed and open TSS [odds ratio (OR)=0.96, 95% confidence 
intervals (CI) 0.72-1.28]. There was no heterogeneity among the eligible trials (I2=0, 95% 
CI 0-0.65). The compared groups did not differ with respect to mortality (OR=1.04, 95% 
CI 0.78-1.39) or intensive care unit (ICU) length of stay [two RCTs: 12.3 (SD 1.1) vs 
11.5 (1.4) days and 15.6 (13.4) vs 19.9 (16.7) days]. However suctioning with closed 
systems was associated with longer MV duration (weighted mean differences: 0.65 days, 
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95% CI 0.28-1.03) and higher colonization of the respiratory tract (OR=2.88, 95% CI 
1.50-5.52) than open TSS. 
                                       Another metaanalysis done by Jongerden etal(13) also did not 
find any difference between the two suctioning systems with regard to ventilator-
associated pneumonia and mortality.But they found that compared with OSS, 
endotracheal suctioning with CSS significantly reduced changes in heart rate (four 
studies, 85 patients; weighted mean difference, -6.33; 95% confidence interval, -10.80 to 
-1.87) and changes in mean arterial pressure (three studies, 59 patients; standardized 
mean difference, -0.43; 95% confidence interval, -0.87 to 0.00) but increased 
colonization (two studies, 126 patients; relative risk, 1.51; 95% confidence interval, 1.12–
2.04).They also found CSS to be more expensive than OSS. 
                                             Another metaanalysis done in our institution(Peter etal)(12) 
also didnot demonstrate a superiority of CES over OES with respect to VAP or mortality. 
However they went on to say that  in developing countries where the space allocated to 
individual beds may be restricted,close proximity of beds may lead to environmental 
contamination of the respiratory tract. The high incidence of pulmonary tuberculosis in 
developing countries poses greater risk to the health personnel, and the mode of 
suctioning assumes greater importance. Thus opined that studies comparing CES with 
OES may be more relevant in the developing world and may not be paramount in 
countries where occupational health and safety concerns preclude the use of OES and 
where the ease of use as well as reduced nursing time with CES may override cost 
concerns.They also stressed about the increased need for trials from the developing 
countries which was the basis for doing this trial. 
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METHODOLOGY 
 
This trial was a Randomized controlled equivalence trial (RCT) comparing closed 
endotracheal versus open endotracheal suctioning in mechanically ventilated medical 
intensive care unit patients. Randomization was performed using varying block sizes and 
was computer generated. Programme allocation was concealed with the use of sealed 
envelopes. 
          It was a prospective study which looked at all the patients admitted to ICU on 
ventilator. Patients were enrolled after informed consent. They were randomized into 
either the open or closed suction arm. Data collection: 
            After the patient is recruited to the trial, all relevant data were collected in DATA 
Abstraction forms(ANNEXURE II)that included the following (copy of data abstraction 
form enclosed). 
*Indication for admission 
*Past medical history 
*Vital signs 
*Arterial blood gas 
*Oxygen saturation using a pulse oximeter 
*Chest Radiograph 
*Ventilator settings at admission 
*In patients who fulfill the criteria of Ventilator associated pneumonia, suction tip culture 
and sensitivity and Blood culture and sensitivity 
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*Data regarding anti-microbial therapy  
*APACHE ll score(ANNEXURE III) 
Data was collected till the duration of hospitalization in ICU, death or discharge from 
ICU.  
The results were compared and analyzed statistically to see if there are significant 
differences between the usage of closed endotracheal suctioning compared to open 
endotracheal suctioning in terms of the parameters studied. 
                                                
             The results were analyzed using SPSS version 15. Data was analysed statistically 
initially comparing each variable by internal cohort while looking at the outcome. Chi 
square test was the test of significance in this study. Mann-whitney U test was used for 
the comparison of medians. . Odds ratio (OR) and confidence intervals (CI) were 
calculated and a ‘p’ value less than 0.05 was considered statistically significant. All 
reported p values are two-sided. Univariate analysis and multivariate analysis were 
performed to assess the risk factors for clinical outcome among he study patients. 
 
                        The study design and methods were approved by the Fluid Research 
Committee, Christian Medical College, Vellore.The study was funded by Fluid Research 
Committee, Christian Medical College, Vellore and Tyko Health care who sponsored the 
closed suction catheters.They did not have any role in the design,conduct,manuscript 
writing of any part of the study. 
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 Participants 
  
 Adult patients (aged 18 years or over) admitted to the medical ICU requiring 
invasive mechanical ventilation at admission or within 24 hours of admission to the ICU 
were enrolled to the study. 
 
Intervention 
All patients who are invasively mechanically ventilated require toileting of the 
respiratory tract for the purpose of clearing respiratory secretions. This was normally 
performed in our ICU after disconnection of the respiratory circuit and employing a 
single-use-suctioning catheter under aseptic precautions. Given the clinical equipoise 
comparing open versus the more recently described closed method of endotracheal 
suctioning; patients was randomized to have either open or closed endotracheal 
suctioning. Closed endotracheal suctioning was performed without disconnection from 
the respiratory circuit employing multi-use in-line-suctioning catheters.   
 
Inclusion Criteria: 
1) All adult patients (> 18 years) presenting to Medical ICU.   
2) Patients on mechanical ventlation at admission or requiring invasive mechanical 
ventilation within 24 hours of admission to medical icu . 
3) Willingness to participate in the trial 
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Exclusion Criteria: 
1) Patients not requiring invasive mechanical ventilation 
2) Patients unwilling to participate 
3) High respiratory supports where the clinician deems that patients should have 
closed endotracheal suctioning 
4) Post cardiac arrest 
 
Withdrawal criteria: 
1) Patient unwilling to continue participation in the trial. 
 
Outcome measures 
            The following outcome parameters were specifically assessed in this study.  These 
outcomes are defined as follows: 
  
. 
1. Ventilator associated pneumonia was considered if the following criteria are 
observed(25).   
              New and persistent radiographic infiltrate plus 2 of the following: 
• Body temperature > 38o Celsius or < 36o Celsius without obvious extra 
pulmonary infectious source,  
• White blood cells >10, 000 or < 4000. 
• Macroscopically purulent tracheal aspirate 
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A postmortem study had established 69% sensitivity and 75% 
specificity for the above diagnostic rule(54). 
The CPIS score was used along with the above criteria to 
corroborate the diagnosis of VAP.     
Early VAP-VAP developing <4 days.     
Late VAP-VAP developing >4 days. 
2. Mortality: defined as deceased when discharged from hospital or ICU.  
3. Left basal collapse: as per the radiological findings that would be reported by a 
radiologist blinded to the study. 
4. Cost: included costs of suctioning (catheter cost, gloves) and not for the full 
hospital  admission.  
5. Arterial desaturation: defined as the saturation drop of > 5% and/or < 90% or 
more as picked up by the saturation probe of the pulse oximeter. 
 SAMPLE SIZE CALCULATION: 
               Though incidence of VAP can range from 6.8% to 44% as shown by various 
studies, a meta analysis done in our institution showed an overall incidence of 18.63% in 
open suctioning group and 19.75% in the closed suctioning group(personal 
correspondence,5). An equivalence study with 80 percent power and 5% alpha error was 
planned so that a difference of upto 14 % would be cosidered as an equivalent difference 
between the two groups ie:there is no difference between the two groups. 
Hence the sample size taken into each arm was 100. 
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RESULTS 
 
Population characteristics: 
A total of 693 were admitted to the medical ICU (MICU) during the time 
period of June 1st 2007 to Feb 14th 2008.Out of 693 patients 448 were intubated and 
ventilated. 248 patients were excluded (the reasons for which are given in figure 4) and 
200 patients were randomized into closed (N=100) and open (N=100) suction arms. 
The baseline characteristics are shown in Table12A and 12B.Both groups 
had similar population charecteristics except for ischaemic heart disease which were 
more common in the open group(P = 0.018).The mean APACHE score for open group 
was 21.05(SD-6.16) and for closed group was 20.82(SD-6.33)which was not statistically 
different. 
There was equal male and female representation. Non Invasive ventilation 
was used in 6% and 4% of patients in the closed and open group prior to invasive 
mechanical ventilation. Most patient underwent emergency intubation and most were 
admitted from the emergency department. 
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Figure 4:Patient flow chart. 
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Table12 A:Baseline charecteristics-Demographic Data and Comorbidities. 
BASELINE 
CHARACTERISTICS 
OPEN SUCTION 
(n=100) 
CLOSED 
SUCTION 
(n=100) 
Demographic data   
Age(mean)      44.01 (16.2)        41.68 (15.9) 
Male 
Female 
          50 
          50 
              54 
              46 
Co morbidities   
Diabetes           16               20 
Hypertension           17               16 
Dyslipidemia            4                1 
Ischaemic Heart Disease            1                9 
Peripheral Vascular Disease            1                0 
Cerebro Vascular Accident            2                1 
Chronic Obstructive Lung 
Disease 
           3                5 
Smoking            4                4 
Malignancy           11                12 
Chronic Liver Disease            0                 1 
Chronic Renal Failure            9                7 
HIV Status            3                 0 
Other Respiratory Diseases            7                 6 
. 
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Table 12B:Baseline characteristics-Prior NIV use, Previous medications, Reason for 
admission and Type of intubation. 
Prior NIV use 
Prior NIV used 
           6                 4 
Reason for admission 
Respiratory failure 
Hemodynamic support 
Neurologic 
Respiratory Failure and 
Hemodynamic support 
           
          40 
          15 
           2 
          
          43 
               
              46 
              13 
               5 
                
              36 
Previous medications 
Steroids 
Aspirin 
Statins 
HAART 
Immunosuppresives 
Others 
None 
       
            5 
            6 
            1 
            3 
          11 
            1 
          73 
               
              5 
              5 
              1 
              0 
             13 
              9 
             67 
Type of Intubation 
Emergency 
Elective 
        
       83 
       17 
            
            78 
            22    
Place Of Intubation 
ICU 
Emergency Department 
Wards 
Previous Hospital 
        
        14 
        49 
        35 
          2 
              
             5 
            51 
            40 
             4 
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                       The most common co-morbidities were diabetes(18%) and 
hypertension(16.5).The number of ischaemic heart disease patients were more in the 
closed group(9%) than open group(1%) with a p value of 0.018.Most of the patients were 
from general medicine(71.5%).The reasons for majority of admissions to medical ICU 
were respiratory failure and haemodynamic instability. 
                               30% patients were already on medications prior to admission to 
medical ICU.The medications included steroids,aspirin,statins,antiretroviral 
medications,immunosuppresives and others(antiparkinsonism drugs,oral hypoglycaemic 
agents).There were no differences in the medications between the two groups(p value-
0.128). 
                              Patients who were started on noninvasive ventilation(NIV) prior to 
intubation were similar in both groups.6% in open group and 3% in closed group with a P 
valve of 0.364.The mean duration of NIV was less than one day in both groups.The place 
of intubation was similar in both groups(p value-0.151) with 17% in the open and 22% in 
closed group were electively intubated (p value 0.372). 
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OUTCOME MEASURES. 
1)Ventilator associated pneumonia and method of suction. 
                          The incidence of ventilator associated pneumonia was calculated 
according to the clinical criteria and was confirmed with more stringent criteria by taking 
into account CPIS score also. Total incidence of VAP was 23.5% according to clinical 
criteria and 14% according to clinical criteria with CPIS score. According to clinical 
criteria the incidence of VAP was 29% in open group and 18% in closed group with a p 
value of 0.067(95% CI 0.91-3.83)(Table 13).When both clinical criteria and CPIS score 
was taken for the diagnosis of VAP,the incidence was 18% in open and 10% in closed 
group with a p value of  .103(95% CI 0.81-4.91).  
Table 13: Incidence of ventilator associated pneumonia and Type of suctioning 
 
 
                                  The number needed to treat to prevent one VAP was 9 patients with 
closed suction catheter,taking into consideration only clinical criteria.When more 
Method of Suction P value Method of diagnosis of 
VAP 
OPEN 
SUCTION 
(N=100) 
CLOSED 
SUCTION 
(N=100) 
 
Tota
l 
Clinical Criteriae 29 18 0.067 47 
Clinical criteriae  and CPIS 
score 
18 10  
0.103 
28 
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stringent criteria of clinical criteria with CPIS score was taken the number needed to treat 
was 12.5 patients. 
2) Early Vs Late VAP                  
                                 VAP was classified into early and late depending on the day of 
development of ventilator associated pneumonia.Of all the people who developed VAP 
44.68 % had a early VAP(Table 14).Out of 29 people who developed VAP  in the open 
group 11 patients had early VAP(37.93%). While in the closed group out of 18 patients 
who developed VAP,10 patients developed early VAP(56%).The incidence of Early VAP 
was similar in both groups(P value 0.81) while Late VAP was significantly more in open 
group(P value 0.03) than the closed group. 
 
    Table 14:Method of suction and Timing of VAP. 
 
Timing of VAP OPEN 
SUCTION 
 
CLOSED 
SUCTION 
 
P Value Total 
EARLY VAP 11 
 
10 
 
0.81 21 
LATE VAP 18 8 0.03 26 
Total 29 18  47 
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3) Emergency Vs Elective intubation 
                             21% of those who required emergency intubation developed VAP 
while 33.33% of those who was electively intubated developed VAP with a P value of  
0.106(Figure 5). 
Figure 5:Method of intubation and VAP(%) 
 
   
  (P value = 0.106) 
 
4) Mortality in VAP 
                            There were no difference in mortality between the patients who 
developed VAP in both open and closed groups(Figure 6). Patients who developed VAP 
had a mortality of 40.42%.). There was no difference in the timing of VAP and 
Mortality;P value 0.06(figure 7). 
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Figure 6: Mortality in patients with VAP.          
 
(P value = 0.99) 
 
5) Microbiology Of VAP                           
                           Of the 47 people who was diagnosed with VAP,endotracheal suction 
from 5 did not grow any organisms,10 patients had monomicrobial infection and rest had 
polymicrobial growth.The most common organism isolated was Pseudomonas(63.8) 
followed by Non fermenting gram negative organisms other than Pseudomonas(NFGNB) 
(36%) and Klebsiella(32%)(Figure 8).There were no difference between the two groups 
in the number of organisms isolated(Table 15 and Figure 9). 
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    Figure 8: Percentage of patients with each organism.  
 
 
Figure 9: Percentage of each organism in patients who developed VAP in Open and 
Closedsuctiongroups. 
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Table 15 :Number(percentage) of Organisms isolated in each group in patients with VAP. 
Organism Open suction(n=56) Closed Suction(35) P Value 
E.coli 4(7.1%) 4(11.42) 0.22 
Pseudomonas 20(35.71) 10(28.57) 0.36 
NFGNB 11(19.64) 6(17.14) 0.71 
Enterococcus 2(3.5) 2(5.7) 0.571 
Pneumococcus 1(1.7) 1(2.8) 0.651 
H.Influenza 3(5.6) 1(2.8) 0.30 
Staph Aureus 5(8.9) 4(11.42) 0.49 
Klebsiella 10(17.85) 7(20) 0.72 
 
 
Figure 10:Median days to VAP and type of suction. 
 
(P value -0.218) 
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                             The median no of days for development of ventilator associated 
pneumonia after the mechanical ventillation was 4 days in open and 3.5 days in 
closed(Figure 10). 
Mortality and method of suction 
                       The total ICU  mortality(Table 16) was 44.5% and hospital mortality 
was 52.5%.Comparing the Hospital mortality(Table 17),Open group had 57% hospital 
mortality rate while Closed group had 48% with a P value of  0.203 which was not 
significant. ICU mortality was 47% in the open group and 42% in the closed groupwith a 
P value of 0.477.  
 
Table 16:Status at discharge from ICU and Type of suction.(P value 0.477) 
 
TYPE OF SUCTION 
STATUS AT 
DISCHARGE 
FROM ICU 
OPEN 
 
 
CLOSED  
 
 
TOTAL 
      P 
VALUE 
ALIVE 53 58 111 
DIED 47 42 89 
TOTAL 100 100  
 
 
 
0.477 
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Table 17:Status at discharge from Hospital and Type of suction(P value 0.203). 
TYPE OF SUCTION 
STATUS AT 
DISCHARGE 
FROM   
HOSPITAL 
 
 
OPEN 
 
 
 
 
CLOSED 
 
 
 
 
TOTAL 
 
 
     P 
VALUE 
ALIVE 43 52 100 
DEAD 57 48 100 
TOTAL 95 105  
 
 
 
0.203 
Basal collapse and method of suction. 
                         Comparing the open and closed groups,the left basal collapse was 
more common in the open group(14%) than in the closed group(5%) with a P value of 
0.03 which was statistically significant(Table 18).The mean duration for development of  
basal collapse was 3.17 days in open group(SD-2.4) and 5.25 days in closed 
group(1.893)(figure 11).9% in the closed group and 4% in the open group developed 
pneumothorax but there was no statisticaly significant difference between the two groups. 
 
Table 18 :Method of suction and left basal collapse( P value 0.03) 
 OPEN SUCTION CLOSED SUCTION P VALUE 
PRESENCE OF 
BASAL 
COLLAPSE 
 
          14% 
 
              5% 
 
           0.03 
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Figure 11:Mean duration(days) to development of basal collapse and method of suction. 
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Method of suction and cost related issues. 
                  Costs were compared between closed and open suctioning 
systems.Suctiong costs included the amount spend for the gloves as well as the suction 
catheters.The median cost of suctiong per day by using closed suction was 293.23 Rs(IQ 
range-92,602) and by using open suction was 211.30 Rs(IQ range 152,560)(Figure 
12).Comparison between the two medians by using the Mann Whitneys test did not yield 
ant significant difference with P value of  0.2. 
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Figure 12: Cost of suction per day in closed and open suction groups.   
Median Cost of suctioning per day 
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( P value 0.2) 
DURATION OF VENTILATION,ICU AND HOSPITAL STAY 
                                             Mean duration of ventilation was 6 days in open group and 5 
days in the closed group(p value -0.651)(Figure 13).The mean duration of stay in ICU 
was 8.01 days in the open group(95% CI:6.58-9.44) and 7.34 days in the closed 
group(95% CI:6.18-8.5).The hospital mean duration of stay was 14.04 days in the open 
group(95% CI-11.52-16.56) and 16.42 days in the closed group(95% CI-13.11-19.73). 
Method of suction and Haemodynamic parameters. 
                  The median duration of suction in both groups were 6 minutes.The 
difference in oxygen saturation was 1.96 and 1.63 in open and closed groups(Table 
19).Mean heart rate increased by 1.58  in open while only .06 in the closed group.Mean 
arterial pressure went up by 0.78 in open and 0.28 in the open group. 
                       
The outcome measures have been outlined in the (Table 20A and 20 B) .  
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Figure 13: Mean duration(days)of Ventilation in ICU and the type of suction. 
 
(P Value:0.651) 
 
Table 19:Haemodynamic parameters and the type of suction. 
 
 
HEMODYNAMIC PARAMETERS 
(MEAN DIFFERENCE BEFORE 
AND AFTER SUCTION) 
 
 
 
 
 
OPEN SUCTION 
 
 
 
CLOSED 
SUCTION 
 
 
 
 
OXYGEN SATURATION 
 
 
 +1.96 
 
+1.63 
HEART RATE +1.58 +0.06 
 
 
 
ARTERIAL BLOOD PRESSURE 
 
 
 
+0.78 
 
 
+0.28 
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Table 20A:Outcome Measures 
 
 
 
Outcome measures 
 
 
 
 
open 
 
 
 
 
closed 
 
 
 
 
Odds ratio 
 
 
 
 
95% 
confidence 
intervel 
 
 
Ventilator associated 
pneumonia 
                        Clinical 
criteriae 
 
29(14.5%) 
 
 
18(9%) 
 
 
1.86 
 
 
 
(0.91 to 3.83) 
Ventilator associated 
pneumonia 
Clinical criteriae with 
CPIS score 
 
 
18(9%) 
 
 
10(5%) 
 
1.98 
 
 
(0.81 to 4.91) 
 
 
Timing of VAP-Early 
VAP 
Clinical criteria  
Clinical criteria +CPIS 
score 
 
 
11(52%) 
6(66%) 
 
 
10(48%) 
7(54%) 
 
 
1.17 
1.49 
 
 
0.65-2.12 
0.87-2.57 
Timing of VAP-Late 
VAP 
Clinical criteria  
Clinical criteria +CPIS 
score 
 
 
18(69%) 
12(80%) 
 
 
8(31%) 
3(20%) 
 
 
4.95 
16 
 
 
2.61-9.46 
7.6-34.18 
 
Mortality rates 
                                      
ICU 
 
 
47(47%) 
 
 
42(52%) 
 
 
1.22 
 
 
(0.67 to 2.23) 
 
 
Mortality rates 
                                 
Hospital 
 
57(57%) 
 
 
48(48%) 
 
 
1.44 
 
 
(0.79 to 2.61) 
 
Left basal collapse 
 
 
14(14%) 
 
 
5(5%) 
 
 
3.09 
 
 
(0.99 to 
10.31) 
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Table 20 B :Outcome measures 
 
Outcome 
measures 
 
Open  Closed Pvalue 
 
Median cost of 
suction per day 
 
211/-(IQ range 
152,560) 
 
293/- (IQ 
range-92,602) 
 
0.20 
 
Median (Range) 
duration of ICU 
stay(days) 
 
 
6.0 (1-35) 
 
 
6.0(1-26) 
 
0.99 
 
 
 
Median 
(Range)duration 
of Hospital 
stay(days) 
 
 
 
12 (1-80) 
 
 
 
11.5 (1-98) 
 
 
 
0.48 
Median(Range) 
Duration 
Of ventilated 
days 
 
6(1-39) 
 
5(1-29) 
 
0.651 
* Mann-whitney U test for the comparison of medians  
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DISCUSSION. 
       
             Though multiple randomized control trials have been done on the advantages and 
cost effectiveness of the closed suction catheter system over open suctioning system,there 
haven’t been any studies about the same done in developing countries. This study from a 
developing country looks at the cost effectiveness of the two suctioning systems and its 
advantages in preventing ventilator associated pneumonia and reducing the mortality and 
the duration of hospital stay.  
              The postulated advantages of closed endotracheal suctioning system have not 
been shown to translate into clinically meaningful improvements(11).  Most of the 
studies done in developed countries did not show any advantage of closed suctioning 
over open suction except in maintaining the hemodynamic parameters during the suction. 
Several metaanalyses have been done on this issue, but none of them found closed 
suctioning to be advantageous over open suctioning system.  
                                    This study was done in the 11 bedded medical ICU of a tertiary 
care hospital in India during the period from June 1st 2007 to Feb 15th 2008.652 patients 
were admitted into the medical ICU during this time period of which 448 were intubated. 
200 patients were finally included into the study of which 100 each were randomized into 
open and closed suctioning systems.The baseline characteristics were similar in both 
groups except for co-morbidities in which ischaemic heart disease patients were more in 
closed group than in open group.However it is unlikely that this variable has affected the 
outcome of the study(VAP).  
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                                   6% of patients in open group and 4% in closed group was tried on 
noninvasive ventilation prior to intubation according to our study.According to the five 
systemic reviews done on noninvasive ventilation,it was  found that noninvasive 
ventilation reduces the intubation rate and mortality,with the greatest benefit being in 
cases of exacerbations of chronic obstructive pulmonary disease(45, 93-96).A 
prospective survey(97) which was done in 42 intensive care units for a duration of 3 
weeks found that Noninvasive ventilation was used in 16% of mechanically ventilated 
patients as first-line therapy. Endotracheal intubation was eventually performed in 40% 
of patients receiving intubation (ie, a 60% success rate).Avoiding intubation obviously 
prevents ventilator associated pneumonia and the complications associated with 
intubation. Therefore the option of providing noninvasive ventilation should always be 
considered prior to initiating invasive ventilation.However the number of patients who 
were tried on non invasive ventilation were small and should be increased. 
                                          The main reasons for admission of patients to the ICU in this 
study were respiratory or hemodynamic instability or both. Poisoning and  drug 
overdosage constituted 22% of  the patients of which majority(19%) were admitted with 
organophosphorous poisoning. 
 
VENTILATOR ASSOCIATED PNEUMONIA. 
                                                                          There was no difference between closed 
and open suction groups with regard to VAP. However when the clinical criteria as per 
the American thoracic Society guidelines was used there was a trend towards a 
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significant difference(P value 0.06).This finding of no difference in VAP rates is in 
keeping with the earlier metaanalysis done in other countries(13,92)).  
                                        The incidence of ventilator associated pneumonia according to 
this study was 23.5% taking only clinical criteria and 14% taking into account both 
clinical criteria and CPIS score. Previous unpublished studies, done prior to three years in 
the medical ICU of this hospital, had shown the incidence of  VAP to be 17%(Dr Cherian 
R,personal communication)(102) in 1999 and 7-8.5%(personal 
communication,Dr.Chacko.B,103, Dr Pichamuthu K ,104) in 2005-2006.However the 
increase in VAP rates in this study could be attributed to the fact that ,the X-rays were 
reported by an expert radiologist. Studies from India have reported VAP rates to be  
16.7%(105) and 47%(21).VAP rates in this study were comparable to that reported in the 
systemic analysis done earlier(10, 12-14). 
                                         There were no significant differences between open and closed 
groups in the timing of VAP(ie;early or late VAP).The timing of VAP did not vary 
between patients who were electively intubated and those who required emergency 
intubation. Median duration of development of ventilator associated pneumonia was 4 
days, similar to other studies(30). Most of the studies done on ventilator associated 
pneumonia identified gram negative bacteria as the most common organism causing 
ventilator associated pneumonia(106-108).In our study also, of patients diagnosed with 
VAP,the endotracheal aspirate culture showed significant growth of Pseudomonas 
aeruginosa in 63.8%.36.17% of the patients grew Staphylococcus aureus and Klebsiella 
pneumoniae. 
75 
 
                        Each closed suction catheter was used for a maximum period of one week. 
Trials elsewhere have shown that prolonged use of CSS(closed suctioning system) was 
associated with increased microbial colonization of the device(22) without raising the 
incidence of VAP (98-100) and was considered safe and cost-effective(22, 98-100).Also 
a survey done among 27 ICUs in the United States revealed that CSS devices were 
changed every 72 hrs, “as needed,” or weekly in 37% of ICUs (101), with no negative 
effects mentioned. Hence in our study the closed suction catheter was used for a 
maximum duration of one week 
                          Previous studies have shown that in early onset VAP (<5 days), 
methicillin-sensitive S.aureus, Streptococcus pneumoniae, and Haemophilus influenzae 
are the most common pathogens, whereas methicillin-resistant S. aureus (MRSA), P. 
aeruginosa, Acinetobacter baumannii and Stenotrophomonas maltophilia are more 
frequent in late onset VAP (≥5 days)(108-110).However, Pseudomonas aeruginosa 
emerged as the most common isolate in both early onset and late onset pneumonia in our 
study.Earlier studies(102, 103) done in this hospital also showed Pseudomonas 
aeruginosa to be the most common organism(35.5%)(103) associated with VAP, 
followed by MRSA(7.2%)(103)(methicillin resistant Staphylococcus aureus). 
MORTALITY 
                         In our study the crude mortality rates were 40% in patients who 
developed VAP. . No difference was established with respect to mortality or length of 
stay in ICU or hospital between the two groups.Patients with VAP have a significantly 
higher morbidity and mortality(28, 37, 111). Heyland et al.(37) reported the crude 
mortality rate of VAP as 23.7%. In another study, the crude mortality rates for VAP cases 
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was 65.0% and they found that the mortality rates were highest in high risk 
pathogens(30). Previous studies done in this hospital showed a mortality rate of 
61%(103) in patients with VAP The randomized control trials comparing the open and 
closed suction also did not find any difference between open and closed groups with 
respect to mortality or length of stay(45, 92).Though the above trials showed that the 
duration of mechanical ventilation was significantly lower in open endotracheal suction 
group,our study did not show any significant difference between the two groups(Open 
group-6 days,Closed group 5 days,P value-0.651). 
 
LEFT BASAL COLLAPSE 
                              This study found a statistically significant difference in the 
development of left basal collapse between open and closed suctioning systems favouring 
closed Open suctioning involves disconnection of ventilator from the endotracheal tube. 
Disconnection itself can result in airway pressure drop and loss of lung volume,but a 
further volume decrease is observed during suctioning(82) due to the generation of 
negative pressure in the airway.One of the disadvantages of closed suctioning systems 
which has been cited, is the risk of producing high negative pressures during the suction 
much more than that which is produced with open suctioning system(19).Due to the 
above reasons we  looked at the left basal collapse in open and closed groups..The mean 
duration of developing collapse was 3.69days(SD- 2.469).We are unable to explain this 
increase in the open group,but there is definitely no increase of basal collapse in the 
closed group. 
SUCTION-COST AND RELATED ISSUES. 
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                                                                                               In our study that number 
needed to treat was 12.5 patients on a closed suction catheter to prevent one ventilator 
associated pneumonia though the difference was not statistically significant at a P value 
of 0.05. Considering that the number needed to treat to prevent one ventilator associated 
pneumonia is 12.5 patients with closed suction catheter,and that the mean duration of 
ventilation is 6 days with additional cost of suction in closed group being 81.7 Rs per day 
compared to open group,the total cost for preventing one ventilator associated pneumonia 
would be 10490.2 Rs. If a patient developes VAP,the common antibiotics used in our 
ICU are Inj.Piperacillin Tazobactem or Inj.Meropenem which for a duration of 10 days 
would cost 23640 to 47370 Rs respectively.This cost would cover only the antibiotic cost 
and does not cover the cost of increased hospital stay and for other morbidity related 
costs associated with VAP,which when considered would increase the cost much more 
for a patient with VAP. Hence taking into account the cost involved in treating a 
ventilator associated pneumonia,the use of closed suction catheter should definitely be 
considered in all ventilated patients,though a larger study needs to be done to prove the 
difference statistically before this can be made a standard of care.  
                                               In a developing country like India,one of the most important 
factors considered prior to implementation of a new intervention,especially when there 
are no clinically proven benefits, is cost effectiveness.Studies done in the west have not 
given any clear answer regarding the cost difference between the two suctioning 
systems.Two of the studies(21, 112) have reported higher costs for the closed suctioning 
system while others(17) have reported lower costs for the same.One study(28) showed 
that when length of mechanical ventilation was lower than 4 days, the cost was higher 
78 
 
with CTSS than with OTSS (7.2±4.7 Euros vs 1.9±0.6 Euros; p<0.001); and when length 
of mechanical ventilation was higher than 4days, the cost was lower with CTSS than with 
OTSS (1.6±2.8 Euros vs 2.5±0.5 Euros; p<0.001). Our study showed that there was Rs.82 
difference in the median cost of suction per day between the two groups. 
 
SUCTIONING TIME AND THE HEMODYNAMIC PARAMETERS. 
                                 Our study did not show any significant changes in the arterial 
saturation between the two suctioning groups. The mean differences in the blood pressure 
and heart rate change between the two suctioning systems were small and no conclusions 
could be drawn from the results. However studies(13) have shown significant changes of 
the above parameters between the CSS and OSS favouring closed suction. This 
difference could be due to the small sample size in our study and hence further studies 
would be needed to assess the same.     
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LIMITATIONS. 
1) Baseline charecteristics showed significant difference between the two groups 
with respect to ischaemic heart disease. However it is not likely to have affected 
the outcome as no studies have shown increased or decreased VAP with IHD. 
2) Patients who got randomized included those who were intubated in the wards and 
then shifted into medical ICU. Though most patients were shifted within 3-4 
hours,there were a subset in whom open suction would have been used in the 
wards before randomization. 
3) Haemodynamic parameters in relation to suctioning could not be assessed for all 
patients included in the study due to operational reasons. 
4) Costing only looked at the suction costs and did not include indirect costs like 
nursing time,among others. 
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CONCLUSIONS 
      In this randomized control trial 200 patients were included and they were randomized 
into two arms,closed endotracheal suction and open endotracheal suction. 
1) The incidence of ventilator associated pneumonia was 23.5% if only clinical 
criteriae was used for the diagnosis and 14% taking into account both clinical 
criteriae and CPIS score. 
2)  There was no difference between the Closed and Open suction groups with 
regards to the incidence of ventilator associated pneumonias. However ,there was 
a trend towards a difference in two groups with regard to ventilator associated 
pneumonia favoring closed suction when clinical criteria as proposed by the 
American thoracic society guidelines was used. However, considering more 
stringent criteria(Clinical criteria + CPIS score) to diagnose VAP,this trend was 
not seen.Late VAP was significantly more in open group(P value 0.03) than the 
closed group 
3) The mortality,duration of stay in ICU or hospital and the duration of ventilation 
was not significantly different between the two groups. 
4) Surprisingly the incidence of left basal collapse was significantly more in the 
open suctioning system compared to the closed suction. 
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5) The cost of suctioning per day was 211Rs in the open group and 293Rs in the 
closed group. 
6) The additional direct cost incurred to prevent one VAP by using the closed 
suction was 10490.2Rs while the cost of treating one VAP in our ICU is 23640 to 
47370 Rs. 
7) The study did not find any difference between the two groups with regard to the 
suctioning time and the Hemodynamic parameters.  
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ANNEXURE I
  
 
 
                 Clinical pulmonary infection score  
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ANNEXURE II 
Data abstraction form – Suctioning study PATIENT STUDY NUMBER  
 
OPEN SUCTIONING  /  CLOSED SUCTIONING 
 
Patient name:        Hospital number: 
Date of birth:        ICU number: 
ICU Admission:       ICU discharge:   
APACHE II score:       SAPS: 
Respiratory failure Hemodynamic support Neurologic Monitoring Poisoning 
 
Intubation status: Previous hospital / E.D / Wards / On ICU arrival / During ICU stay 
Lag time from admission to intubation:           (hours) Emergency intubn. / Elective intubn. 
Prior/subsequent NIV: Yes / No    Duration of NIV: _____hours 
Diabetes type 1 Diabetes type 2 Hypertension Hypercholesterolemia 
IHD PVD Previous CVA COPD 
Current smoker Ex-smoker Other Resp. disease Current Mg 
Chronic liver disease Chronic renal failure HIV Previous Mg 
 
Steroids Aspirin Statins PPI 
Immunosuppressive HART Others (list) 
 
 
Antibiotics (list names 
and duration at time of 
recruitment  
VAP diagnosed: Yes / No Early VAP / Late VAP  Time from MV to VAP (days): 
 
CLINICAL CRITERIA FULFILLED:   YES / NO 
CPIS SCORE (BASELINE) ______  SCORE AT 72 HOURS ______ 
 
Organisms grown (With CFU & sensitivity) 
  (1) 
(2) 
  (3) 
Antibiotic changed for VAP: Yes / No   New antibiotics: 
Duration of therapy: 
Day 1 2 3 4 5 6 7 8 9 10 
No of suctions           
Cost of catheter           
Cost of glove           
Total cost/d           
 
Day 11 12 13 14 15 16 17 18 19 20 
No of suctions           
Cost of catheter           
Cost of glove           
Total cost/d           
Total suction cost for entire ventilation:    Cost of suctioning/day: Rs.Left basal 
collapse; Yes / No     
If Yes, day developed post intubation:  Day resolved:  
 
Duration of ICU stay: _____ hours   Duration of hospital stay: ________days 
Duration of ventilation:  _____ hours 
Circle 
primary 
reason for 
ICU 
admission 
Co-
morbidities 
Meds  
COSTS 
VAP 
diagnosis 
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ICU outcome: Died / Alive / Discharged at request Hospital outcome: Died/Alive/Request 
 
Date        
Start time        
Finish time        
Duration (sec)        
Start SaO2        
Finish SaO2        
Start HR        
Finish HR        
Start MAP        
Finish MAP        
New and persistent radiographic infiltrate: Present / Absent, If present need at least 2 to ∆ VAP 
Temperature >38oC or <36oC (without obvious extra pulmonary 
infection) 
 
WBC count >10, 000 or < 4000  
Purulent tracheal aspirate Present   
Culture (>1000 CFU) Present   
Antibiotic change after culture 
report 
Yes  
                         Points                   0                                    1                              2 
Temperature ≥ 36.5 and ≤ 38.4 ≥ 38.5 and ≤ 38.9 ≥ 39 and ≤ 36 
P/F ratio 240 or ARDS  ≤240 and no ARDS 
X-ray patch No infiltrate Diffuse (or patchy) 
infiltrate 
Localised infiltrate 
Total count 
 
≥ 4000 and ≤ 11000  < 4000 or > 11000 < 4000 or > 11000 
+ 
band forms ≥ 50%  
Purulent secretions 
 
Absence of tracheal 
secretions 
Presence of non-purulent 
tracheal secretions 
Presence of 
purulent tracheal 
secretions 
 
Temperature ≥ 36.5 and ≤ 38.4 ≥ 38.5 and ≤ 38.9  ≥ 39 and ≤ 36 
P/F ratio 240 or ARDS  ≤240 and no ARDS 
X-ray patch No infiltrate Diffuse (or patchy) 
infiltrate 
Localised infiltrate 
Total count ≥ 4000 and ≤ 11000 < 4000 or > 11000 < 4000 or > 11000 + 
band forms ≥ 50%  
Purulent secretions Absence of tracheal 
secretions 
Presence of non-
purulent tracheal 
secretions 
Presence of purulent 
tracheal secretions 
Progression of  
X-ray patch 
No progression  
 
 
 
Progression (after 
CHF/ARDS excluded) 
Culture of tracheal 
aspirate  
 
 
 
Pathogenic bacteria 
cultured in rare or 
light quantity or no 
growth 
 
Pathogenic bacteria 
cultured in moderate 
or heavy quantity 
 
Pathogenic bacteria 
cultured in moderate or 
heavy quantity + Same 
pathogen seen on Gram 
stain 
Clinical 
score 
 
YES  
 
NO 
CPIS 
Baseline 
score 
 
TOTAL 
SCORE 
 
CPIS 72 
hours 
 
TOTAL 
SCORE 
Sats  
 
 
STUDY 
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APPENDIX III 
                                                           CONSENT FORM: 
 
        INFORMATION TO THE PATIENT 
             A patient in the ICU on the ventilator needs frequent suctioning of the 
endotracheal tube to remove collected secretions. This can be done in two ways. One 
method is using the open suction which requires the patient to be disconnected from the 
ventilator during that period. This has several disadvantages like possible hypoxic attacks 
if prolonged disconnection, increase in heart rate and blood pressure, contamination of 
the surrounding environment and exposure to contaminants in the environment. This may 
lead to increase incidence of ventilator associated pneumonias ( VAP) .The other method 
is using the closed suction during which the patient need not be disconnected from the 
ventilator, thus avoiding the above mentioned problems. However, the efficacy of one 
over the other has not been proved in studies done in developed countries. 
         This study is being done to determine the difference in incidence of VAP with the 
usage of both types of suctioning, considering the differences in the ICU settings in 
developed and developing countries. 
          If you volunteer for the study your patient would be randomly put into two groups 
to receive either closed or open endotracheal suctioning. 
          This study is purely voluntary. You may withdraw from it at any point in time. The 
care provided to your patient will not be affected by it.  
        PATIENT CONSENT SHEET 
          I,_______________________________, _______________ of 
____________________ 
am well aware that my relative is included in the study "Difference in incidence of 
ventilator assosciated pneumonia with respect to use of open and closed suction catheters 
in patients admitted to the Medical ICU and that the data collected can be used for 
publication purposes. I am willing for the same.  
 
Signed ___________________________________Relationship with the patient 
________________    
           
Witness __________________________________Researcher 
_______________________________ 
 
Date _______________________ 
 
 
In case of any queries:contact Dr.Deepu David,Medicine Registrar,CMCH.Phone 
No:2282178. 
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ANNEXURE IV 
 
  
O  
APACHE II SCORING SYSTEM  
POINT SCORE  
+1 0 
* 
PHYSIOLOGIC  
VARIABLE  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
†  
Temperature,  
core (°C)  
Mean arterial  
pressure  
(mm Hg)  
Heart rate  
Respiratory  
rate (non-  
ventilated or  
ventilated)  
Oxygenation:  
a) FIO   ≥ 0.5:  
2  
use A-aDO2  
b) FIO  2 < 0.5:  
use PaO  
2   
Arterial pH  
Serum Na  
(mMol/L)  
Serum K  
(mMol/L)  
Serum creati-  
nine (mg/dL);  
double point  
score for  
acute renal  
failure  
Hct (%)  
WBC  
(in 1000s)  
Glasgow coma  
score (GCS)  
+4 +3 
≥ 41°    39-40.9°  
+2 
— 
+1 +2 +3 +4 
38.5-38.9°    36-38.4°    34-35.9°    32-33.9°    30-31.9°    ≤ 29.9°  
—               70-109             —             50-69              —             ≤ 49  ≥160    130-159   110-129  
≥180    140-179   110-139  
≥ 50        35-49            —  
—  
25-34 
70-109  
12-24  
—  
10-11 
55-69 
6-9  
40-54  
—  
≤ 39  
≤ 5  
≥ 500    350-499   200-349  — < 200  — — — — 
— — — — > 70  61-70 — 55-60  < 55  
≥ 7.7     7.6-7.69  —
≥ 180    160-179   155-159  
≥ 7  
 
≥ 3.5  
6-6.9 
2-3.4 
—  
1.5-1.9  
7.5-7.59  
150-154  
5.5-5.9  
—  
7.33-7.49  
130-149  
3.5-5.4  
0.6-1.4  
—  
—  
3-3.4 
—  
7.25-7.32   7.15-7.24    < 7.15  
120-129     111-119  
2.5-2.9  
 
< 0.6  
— 
— 
≤ 110  
 
< 2.5  
—  
≥ 60  
≥ 40  
— 
— 
50-59.9  
20-39.9  
46-49.9  
15-19.9  
30-45.9  
3-14.9  
—
—
20-29.9  
1-2.9  
— 
— 
< 20  
< 1  
Score = 15 minus actual GCS  
Acute physiology score is the sum of the 12 individual variable points.  
Add 0 points for age < 44; 2 points, 45-54 yr; 3 points, 55-64 yr; 5 points, 65-74 yr; 6 points ≥ 75 yr.  
Add  chronic  health  status points:  2  points  if  elective  postoperative  patient  with  immunocompromise  or  history  of  
severe organ insufficiency; 5 points for nonoperative patient or emergency postoperative patient with immunocom-  
promise or severe organ insufficiency. ‡ 
(13)   Serum HCO3  
(venous-  
§ ≥ 52  41-51.9  — 32-40.9  22-31.9  — 18-21.9  15-17.9  < 15  
* 
mMol/L) use  
only if no  
ABGs  
APACHE II Score = acute physiology score + age points + chronic health points. Minimum score = 0; maximum  
score = 71. Increasing score is associated with increasing risk of hospital death.  
† Choose worst value in the past 24 h.  
‡ Chronic  health  status:  Organ  insufficiency  (eg,  hepatic,  cardiovascular,  renal,  pulmonary)  or  immunocompro-  
mised state must have preceded current admission.  
§ Optional variable; use only if no ABGs.  
Adapted from Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: A severity of disease classifica-  
tion system. Critical Care Medicine 13:818-829, 1985.  
 
